SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

09 Jan 2025 Evaluate
The revenue slipped marginally during the December 2024 quarter. A decline of about Rs. 122.12 millions was observed as compared to Rs. 127.06 millions during the corresponding quarter last year.Profit after Tax for the quarter ended December 2024 saw a decline of -32.30% from Rs. 13.22 millions to Rs. 8.95  millions.Operating Profit reported a sharp decline to 56.23 millions from 64.08 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 122.12 127.06 -3.89 343.81 333.30 3.15 448.81 516.22 -13.06
Other Income 0.08 0.30 -73.33 46.51 0.30 15403.33 0.39 0.36 8.33
PBIDT 56.23 64.08 -12.25 203.11 157.84 28.68 211.23 215.23 -1.86
Interest 18.38 22.22 -17.28 58.23 62.60 -6.98 77.78 76.51 1.66
PBDT 37.85 41.86 -9.58 144.88 95.24 52.12 133.45 138.72 -3.80
Depreciation 22.48 22.76 -1.23 67.71 68.64 -1.35 92.91 92.66 0.27
PBT 15.37 19.10 -19.53 77.17 26.60 190.11 40.54 46.06 -11.98
TAX 6.42 5.88 9.18 13.32 8.36 59.33 15.33 19.72 -22.26
Deferred Tax 0.28 -0.09 -411.11 -2.62 -1.11 136.04 -1.43 9.41 -115.20
PAT 8.95 13.22 -32.30 63.85 18.24 250.05 25.21 26.34 -4.29
Equity 161.29 149.04 8.22 161.29 149.04 8.22 149.04 149.04 0.00
PBIDTM(%) 46.04 50.43 -8.70 59.08 47.36 24.75 47.06 41.69 12.88

Vivo Bio Tech Share Price

29.30 0.38 (1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×